IP Library Granted Patent US 7,504,486
Granted Patent B2
US 7,504,486 · App. 10/391,289 · Granted Mar 17, 2009

Determination and uses of the atomic structures of ribosomes and ribosomal subunits and their ligand complexes

Assignee: Yale University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,504,486
App. No.
10/391,289
Granted
Mar 17, 2009
Kind
B2
Abstract

The present invention provides methods for producing high resolution crystals of ribosomes and ribosomal subunits as well as the crystals produced by such methods. The x-ray diffraction patterns of the crystals provided by the present invention are of sufficiently high resolution for determining the three-dimensional structure of ribosomes and ribosomal subunits, for identifying ligand binding sites on ribosomes and ribosomal subunits, and for molecular modeling of ligands which interact with ribosomes and ribosomal subunits. The present invention provides methods for identifying ribosome-related ligands and methods for designing ligands with specific ribosome-binding properties. Thus, the methods of the present invention may be used to produce ligands which are designed to kill or inhibit any specific target organism(s).

Claims (11)

1. A method of growing a crystal of a 50S ribosomal subunit from Haloarcula marismortui comprising:

(a) isolating a 50S ribosomal subunit from Haloarcula marismortui ;

(b) precipitating the 50S ribosomal subunit;

(c) back-extracting or resuspending the precipitated 50S ribosomal subunit to obtain a solution;

(d) seeding the back-extracted or resuspended solution of step (c);

(e) growing a crystal of the 50S ribosomal subunit from the seeded solution of step (d) by vapor diffusion at room temperature;

(f) harvesting the crystal from step (e);

(g) stabilizing the harvested crystal by gradual transfer of said crystal into a series of solution containing high salt concentration of from about 1.2 M to 1.7 M; and

(h) maintaining the crystal under high salt concentration, wherein the crystal (i) is untwinned, (ii) has an average thickness greater than about 15 μm, and (iii) diffracts X-rays to a resolution of at least 2.7 Å.

2. The method of claim 1 further comprising:

(i) flash freezing the crystal of step (h).

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jan 5, 2018
From: SUCHARD SA LLC
To: MELINTA SUBSIDIARY CORP. (F/K/A MELINTA THERAPEUTICS, INC.)
Reel/Frame 044547/0939 →
SECURITY INTEREST Recorded Jun 28, 2017
From: MELINTA THERAPEUTICS, INC.
To: SUCHARD SA LLC
Reel/Frame 042854/0753 →
CHANGE OF NAME Recorded Oct 17, 2013
From: RIB-X PHARMACEUTICALS, INC.
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 031432/0123 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 23, 2003
From: MOORE, PETER B.; BAN, NENAD; NISSEN, POUL; HANSEN, JEFFREY; STEITZ, THOMAS A.
To: YALE UNIVERSITY
Reel/Frame 014611/0770 →
Continuity (2)
Division 0963570800 · Aug 9, 2000
Related Publication 20030232779A1 · Dec 18, 2003